| # | Drug | Count |
|---|---|---|
| 0 | EMICIZUMAB | 139 |
| 1 | RIVAROXABAN | 134 |
| 2 | ASPIRIN | 97 |
| 3 | ASPIRIN 325 MG | 93 |
| 4 | ASPIRIN 81 MG | 93 |
| 5 | ADALIMUMAB | 72 |
| 6 | CLOPIDOGREL | 61 |
| 7 | FUROSEMIDE | 60 |
| 8 | SODIUM CHLORIDE | 54 |
| 9 | DABIGATRAN ETEXILATE | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COLLOIDAL OATMEAL 1% | 1 | 0.0714 |
| 1 | FITUSIRAN | 3 | 0.0536 |
| 2 | MARSTACIMAB-HNCQ | 4 | 0.0388 |
| 3 | AMINOCAPROIC ACID | 15 | 0.0187 |
| 4 | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 1 | 0.0167 |
| 5 | ANTI-INHIBITOR COAGULANT COMPLEX | 18 | 0.0163 |
| 6 | COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED | 1 | 0.0147 |
| 7 | EMICIZUMAB | 139 | 0.0108 |
| 8 | LULICONAZOLE | 1 | 0.0057 |
| 9 | DEXTRAN, HYPROMELLOSE | 1 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 177 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 132 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 101 |
| 3 | Loop Diuretic [EPC] | 70 |
| 4 | Osmotic Laxative [EPC] | 64 |
| 5 | Corticosteroid [EPC] | 55 |
| 6 | P2Y12 Platelet Inhibitor [EPC] | 49 |
| 7 | Proton Pump Inhibitor [EPC] | 49 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 48 |
| 9 | Benzodiazepine [EPC] | 45 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antithrombin-directed RNA Interaction [EPC] | 3 | 0.0536 |
| 1 | Small Interfering RNA [EPC] | 3 | 0.0187 |
| 2 | Antifibrinolytic Agent [EPC] | 22 | 0.0022 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0021 |
| 4 | Neuraminidase Inhibitor [EPC] | 2 | 0.0008 |
| 5 | Selectin Blocker [EPC] | 1 | 0.0007 |
| 6 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 7 | Factor Xa Inhibitor [EPC] | 177 | 0.0006 |
| 8 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 9 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |